Metalloproteinase oligopeptides and their therapeutic use

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S328000, C530S345000, C530S350000, C424S192100, C424S193100, C424S277100

Reexamination Certificate

active

08067009

ABSTRACT:
The invention discloses identification and therapeutic use of matrix metalloproteinase oligopeptides and peptidomimetics. The oligopeptides are used for making antibodies. The antibodies are used for diagnostic and treatment purposes of various diseases. In particular, the diseases may involve the mechanism of degradation of extracellular matrix by MMP's during cell proliferation cycle. Suppression of MMP activity seems to arrest tumor growth during cancer progression. MMP oligopeptides were used as vaccines to treat mice having murine melanoma B16FO induced tumor. There was a significant drop in tumor weight and size for the group of mice that were immunized with MMP oligopeptide.

REFERENCES:
patent: 5646027 (1997-07-01), Ye et al.
patent: 2003/0139345 (2003-07-01), Netke et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Metalloproteinase oligopeptides and their therapeutic use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Metalloproteinase oligopeptides and their therapeutic use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metalloproteinase oligopeptides and their therapeutic use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4309335

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.